---
title: "Aspire Biopharma says ASPBW warrants now carry exercise price of 13,800 per share after reverse splits"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293256360.md"
description: "Aspire Biopharma clarified that its public warrants (ASPBW) now carry an exercise price of $13,800 per share following two reverse stock splits. The warrant ratio was adjusted to 1,200 warrants for one common share. These changes reflect a 1-for-30 reverse split on January 16, 2026, followed by a 40-for-1 reverse split on May 11, 2026."
datetime: "2026-07-20T21:21:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293256360.md)
  - [en](https://longbridge.com/en/news/293256360.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293256360.md)
---

# Aspire Biopharma says ASPBW warrants now carry exercise price of 13,800 per share after reverse splits

-   Aspire Biopharma clarified terms of its public warrants (ASPBW) following two reverse stock splits. \* Exercise price reset to $13,800 per share. \* Warrant ratio adjusted to 1,200 warrants for one common share. \* Changes reflect a 1-for-30 reverse split on Jan. 16, 2026, followed by a 40-for-1 reverse split on May 11, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-033942), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ASBP.US](https://longbridge.com/en/quote/ASBP.US.md)
- [ASBPW.US](https://longbridge.com/en/quote/ASBPW.US.md)

## Related News & Research

- [Aspire Biopharma Updates Public Warrant Exercise Terms](https://longbridge.com/en/news/293260441.md)
- [Vyne Therapeutics issues pre-funded warrants for 133,290 shares in stock exchange deal](https://longbridge.com/en/news/294409414.md)
- [NanoViricides issues warrants exercisable at US$1.75 in US$3.8 million registered direct offering](https://longbridge.com/en/news/294342376.md)
- [Columbus Circle Capital III units begin separate trading of shares, warrants July 31](https://longbridge.com/en/news/294261716.md)
- [Boost Run sets USD 0.01 per warrant redemption, Aug. 20 exercise deadline](https://longbridge.com/en/news/293920690.md)